Rationale: Posttranslational phosphorylation of connexin43 (Cx43) has been proposed as a key regulatory event in normal cardiac gap junction expression and pathological gap junction remodeling. Nonetheless, the role of Cx43 phosphorylation in the context of the intact organism is poorly understood.
G ap junctional communication is essential for normal cardiac impulse propagation. A growing body of literature provides compelling evidence that supports the concept that dysregulation of cell-cell coupling in the heart contributes to a proarrhythmic substrate. 1 The proximate pathological stimuli that result in aberrant cardiac gap junction expression and function are diverse. They include common forms of acquired heart disease, including hypertrophy and ischemic heart disease, 1 as well as rare genetic causes such as the somatic mutations in connexin 40 associated with sporadic cases of atrial fibrillation 2 or the inherited mutations in connexin 43 (Cx43) responsible for oculodentodigital dysplasia. 3 The cardiac connexins (ie, connexins 43, 40, and 45) are all phosphoproteins. Posttranslational phosphorylation is thought to affect multiple aspects of the connexin life cycle, including transport to the plasma and junctional membrane, oligomerization into connexins (hemichannels), gap junction assembly, gating of assembled gap junction channels, and degradative processes that involve lysosomal and proteasomal pathways. 4, 5 Gap junction remodeling (GJR) is likely to reflect perturbations at any number of these steps in the life cycle of connexins.
Cx43, the major ventricular gap junction protein, undergoes posttranslational phosphorylation in its carboxyterminus at as many as a dozen amino acids. Significant progress has been made in the identification of specific kinases and phosphatases that act on Cx43, as well as their specific target sites. Protein kinase A-dependent phosphorylation of Cx43 results in increased trafficking to the plasma membrane 6, 7 ; phosphorylation at casein kinase 1␦ (CK1␦) sites on Cx43 plays a significant role in gap junction assembly 8 -10 ; Cx43 interaction with Src kinase has the dual effect of destabilizing Cx43 interaction with the scaffolding protein ZO-1, which leads to Cx43 internalization/degradation, [11] [12] [13] and downregulating gap junctional cell-cell communication 14 -16 ; mitogen-activated protein kinases inhibit intercellular communication via reduced channel open probability [17] [18] [19] ; and protein kinase C-dependent phosphorylation of Cx43 influences unitary conductance of assembled channels 20 -22 and may be further involved in cell cycle progression. 23 The protein phosphatases PP1 and PP2A colocalize with Cx43 and have been found to be upregulated in heart failure models, which suggests a role in GJR. 24, 25 Many of these data were gleaned from experiments that used pharmacological approaches and from in vitro studies of site-specific connexin mutants. Although these studies have been informative, the relevance of these approaches to in vivo physiology and pathophysiology is uncertain.
CK1␦ phosphorylation of Cx43 occurs at serines 325/328/ 330. Cell culture studies suggest that these sites play an integral role in gap junction assembly and the formation of the slower-migrating phosphoisoforms of Cx43 observed when subjected to SDS-PAGE. 8, 9 Interestingly, recent data indicate that phosphorylation at these sites is markedly reduced in response to cardiac ischemia, and the loss of phosphorylation is associated with relocalization of the protein from gap junctions to the lateral borders of myocytes. 9 Moreover, our laboratory demonstrated that not only acute stressors such as ischemia but also the imposition of chronic pressure-overload hypertrophy resulted in early and progressive dephosphorylation of Cx43 at these same residues, in association with GJR and slowing of impulse propagation. 10 These changes were blunted by mineralocorticoid receptor blockade, a therapy that has been shown to diminish sudden cardiac deaths in patients with heart failure. 26 In the present study, we tested the hypothesis that modulation of posttranslational phosphorylation of Cx43 at this triplet of serines would influence GJR and alter arrhythmic susceptibility. We generated 2 new strains of genetically engineered knock-in mice. Compared with wild-type (WT) mice, cardiac gap junctions in mice that harbored phosphatase-resistant phosphomimetic glutamic acids at residues 325, 328, and 330 (S3E) were resistant to pathological remodeling and to the induction of ventricular arrhythmias. In contrast, introduction of nonphosphorylatable alanines into the carboxyl-terminus (S3A) interfered with gap junction formation and function and promoted a proarrhythmic phenotype. The present data provide the first in vivo evidence to date demonstrating a mechanistic link between Cx43 phosphorylation status, electrophysiological substrate, and arrhythmic susceptibility.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Generation of Cx43 Phosphomutant Constructs and Mutant Mice
Site-directed mutagenesis was performed to introduce the S3E and S3A (residues 325, 328, and 330) into the same gene-targeting vector previously used to conditionally inactivate Cx43 in the heart and other lineages. [27] [28] [29] Cx43 phosphomutant targeting vectors were introduced into the 129/Sv-derived embryonic stem cell line R1, 27, 30 and correctly targeted embryonic stem cell clones were injected into C57BL/6 blastocysts. Highly chimeric male mice were crossed with WT CD1 females to generate F1 Cx43 S3A/WT and Cx43 S3E/WT heterozygous mutant mice, which were then bred to generate homozygous Cx43 S3A/S3A and Cx43 S3E/S3E mice. Both heterozygous and homozygous intercrosses were maintained, and for all experiments, WT littermates were used as controls.
Echocardiography
Left ventricular dimensions and function were assessed by echocardiography as described previously with an ATL 5000CV Ultrasound System (Philips Medical, Bothell, WA). 27
Western Blot Analysis
Total protein lysates and Triton X-100 -insoluble pellet fractions were prepared from the apical two-thirds of the ventricle as described previously. 31 Signals were visualized and quantified with the Odyssey Imaging System (Li-Cor, Lincoln, NE).
Immunofluorescence, Confocal Microscopy, and Cx43 Quantification
Immunofluorescent staining was performed on formalin-fixed, paraffin-embedded sections with rabbit polyclonal anti-Cx43 antibody (Sigma c6219) and mouse anti-N-cadherin antibody (Invitrogen). GJR was quantified by determining the extent of colocalization of Cx43 and N-cadherin at the intercalated discs (CoLocalizer Pro software, CoLocalization Research Software).
Heart Isolation and Optical Mapping
High-resolution optical mapping experiments were performed as described previously with a CMOS video camera (Ultima-L; SciMedia, Inc, Costa Mesa, CA). 27, 32 Epicardial conduction velocity (CV) and optical action potential duration (APD) and APD dispersion measurements were obtained from the left ventricular surface at a basic cycle length of 100 ms.
Electrophysiology Studies
Electrophysiological studies were performed as described previously with a 2F octapolar intracardiac catheter. 33 Standard pacing protocols (single, double, and triple extrastimulation and burst pacing) were performed to test for ventricular tachycardia inducibility. Ventricular tachycardia was defined as Ն4 consecutive beats.
Transverse Aortic Constriction
Transverse aortic constriction (TAC) was performed on male mice at 3 to 4 months of age as described previously. 34 
No-Flow Ischemia Protocol
A Langendorff global ischemia model was performed as described previously. 35 
Statistical Analysis
Data are presented as meanϮSEM and were analyzed by Student t test. For multiple groups, 1-way ANOVA was performed with post hoc Newman-Keuls test. Arrhythmia inducibility was analyzed by Fisher exact test. PϽ0.05 was considered statistically significant.
Results

S3A and S3E Mice Develop Normally
To evaluate the effects of Cx43 phosphorylation on gap junction expression and function in vivo, we generated site-specific knock-in mice that expressed either the S3A or S3E mutations using a strategy identical to that previously used to generate Cx43 oculodentodigital dysplasia mutant mice. 36 Homozygous S3A and S3E mice were grossly indistinguishable from WT controls at birth and throughout development into adulthood (Ͼ3 months). Histological examination of S3A and S3E adult hearts appeared entirely normal, with no evidence of fibrosis, hypertrophy, or myofibrillar disarray (data not shown). There was no statistically significant difference between the 3 genotypes with respect to contractile performance, left ventricular chamber sizes, wall thicknesses, or heart weight-to-body weight ratio (Online Table I ).
Altered Cx43 Phosphorylation and Gap Junction Formation in S3A and S3E Mice
Immunoblotting studies were performed to determine whether the site-specific mutations were associated with changes in Cx43 Figure 1A , upper panel). Heterozygous mice showed intermediate phenotypes. We also determined the banding pattern of Triton X-100 -insoluble protein extracts, which are enriched in junctional membrane proteins. 37 This fractionation resulted in the preferential recovery of more slowly migrating forms of Cx43 for all genotypes ( Figure 1A , lower panel).
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To quantitatively determine whether the site-specific mutants affected the steady state accumulation of Cx43, we performed Western blot analysis of whole-cell lysates and Triton X-100insoluble pellet fractions prepared from the hearts of a cohort of WT, homozygous S3A, and S3E mutant mice. Compared with hearts expressing WT Cx43, the amount of total Cx43-S3A protein found in whole-cell lysates, as well as amounts within the Triton X-100 -insoluble fraction, was significantly reduced to less than 50% of control levels, which is indicative of less accumulation of Cx43 into gap junctions ( Figure 1B ). In con-trast, the abundance of the phosphomimetic S3E mutant protein was indistinguishable from WT levels in both whole-cell lysates and Triton X-100 -insoluble fractions ( Figure 1B) .
To directly visualize gap junctional plaques, we next performed immunofluorescent staining of hearts from each of the 3 strains of mice. Hearts of S3A mice showed significantly less total Cx43 colocalized with N-cadherin at intercalated discs than WT controls or S3E mutant mice (Figures 2A and 2B ). Taken together, these findings are consistent with prior in vitro data that suggested that phosphorylation of Cx43 at serine residues 325/328/330 leads to P2 formation, and they also suggest that inhibition of this phosphorylation event in vivo interferes with normal Cx43 trafficking or stability. 9
S3E Mice Are Resistant to Structural GJR
We previously demonstrated that chronic pressure-overload hypertrophy secondary to TAC results in dephosphorylation of Cx43 at serines 325/328/330, as well as structural GJR and slowing of impulse propagation. 10 To determine whether modification of these sites affected the heart's response to chronic pathological stress, WT and homozygous S3A and S3E mutant mice were subjected to TAC and followed for 4 weeks. Mice of all 3 genotypes exhibited comparable structural remodeling, with deterioration of contractile function after imposition of pressure overload (Online Table I ). As anticipated from our previous work, 10 analysis of whole-cell lysates from WT hearts subjected to TAC showed molecular evidence of GJR, with an obvious shift toward higher-mobility/hypophosphorylated forms of Cx43 compared with sham-operated mice ( Figure 3A) . In contrast, the more rapid electrophoretic mobility of Cx43-S3A 
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and the retarded mobility of Cx43-S3E seen at baseline were largely unaffected by imposition of TAC, consistent with the phosphatase-resistant design of both mutant proteins. However, analysis of Triton X-100 -insoluble fractions, enriched in gap junctions, revealed a significant reduction in abundance of Cx43 in WT hearts and particularly in S3A mutant hearts after TAC, whereas the S3E hearts were resistant to molecular GJR ( Figure  3B ). In agreement with these data, we found by confocal immunofluorescence that although TAC led to significant GJR in WT and S3A mice, the S3E mice were resistant to pathological remodeling, with preservation of Cx43 at the intercalated discs, largely colocalizing with N-cadherin (Figure 2A , compare upper and lower panels; quantification in Figure 2B ). To further examine the relevance of posttranslational phosphorylation of Cx43 at serines 325/328/330, we subjected isolated hearts from WT, S3A, and S3E mice to acute global ischemia, as described previously. 35 Confirming prior studies, there was a significant increase in the amount of P0 Cx43 in WT hearts after ischemia. Postischemic S3A hearts also showed an accumulation in the nonphosphorylated Cx43 band; in contrast, the S3E postischemic hearts displayed significantly less dephosphorylation (Figure 4 ).
S3E Mice Are Resistant to Conduction Slowing
To determine whether these effects on GJR were associated with functional sequelae, we performed optical mapping to quantify CV in WT and mutant mice, both at baseline and after TAC. As shown in Figure 5 , optical mapping of WT and S3A hearts revealed significantly diminished CV max and CV min after TAC, but S3E CV was preserved, consistent with the lack of structural GJR.
Connexin Mutations Differentially Influence Electric Remodeling
Recent data suggest that the intercalated disc may behave as a functional unit, and changes in gap junction expression may influence other ionic currents. 32, 38, 39 Therefore, we also measured action potential parameters in isolated perfused hearts. Interestingly, hearts from S3A mice showed a significant increase in APD dispersion compared with WT and S3E mutants ( Figures 5A-D) . Moreover, the restitution properties of the S3A hearts also differed from the other 2 genotypes; the relationship between coupling interval and APD was steeper in these mice, with a trend toward shorter APD 50 values at short S1S2 coupling intervals and greater APD 50 values at longer coupling intervals ( Figure 5E ). 
S3E Mice Are Less Susceptible to Induction of Ventricular Arrhythmias
A key goal of strategies to modify GJR is amelioration of arrhythmic activity in the intact organism. Accordingly, using 2 different provocative methods, we tested whether the changes in electrophysiological properties identified above were associated with alterations in arrhythmic propensity. Baseline WT and mutant mice were subjected to programmed electrical stimulation with premature extrastimuli. With this protocol, 40% of S3A mice and 33% of WT mice developed ventricular tachyarrhythmias, but none of the S3E mice were inducible. With the more aggressive burst-pacing protocol, 70% of S3A mice and 42% of WT mice developed ventricular tachycardia, but only 18% of S3E mice were inducible, as shown in Figure 6 .
Discussion
Sudden cardiac death due to ventricular tachyarrhythmias results in as many as 462 000 deaths annually in the United States alone. 40 Prior studies suggest that GJR plays an important role in the pathophysiology of these lethal cardiac arrhythmias. Cx43 is the major cardiac gap junction protein, and we have previously shown that the elimination of Cx43-dependent intercellular coupling between cardiomyocytes results in a slowing of ventricular CV and uniform sudden arrhythmic death in mice. 27 These results illustrate the importance of Cx43 to normal cardiac function but do not address the underlying mechanism and functional consequences of pathological GJR that occurs in response to myriad myopathic stimuli associated with acquired forms of heart disease.
The present study was performed to further explore the significance of posttranslational phosphorylation of Cx43 at serines 325/328/330 and the role of this regulatory event in impulse propagation and arrhythmogenicity. Our focus on these particular residues derives from in vitro studies demonstrating the importance of these sites for gap junction formation, as well as our recent observation that dephosphorylation at these residues is an early response to pressure-overload hypertrophy, a clinically important pathological stimulus associated with increased mortality and sudden cardiac death. 41 We established strains of mutant knock-in mice to determine the relevance of these sites in vivo. The results of the present analysis indicated that pseudophosphorylation of Cx43 at serines 325/328/330 (S3E mutant mice) led to gap junctions that appeared resistant to the pathological remodeling associated with both acute (no-flow ischemia) and chronic (TAC) pathological stimuli. Conversely, phosphorylation-deficient S3A mutant mice displayed aberrant gap junction expression even at baseline. Importantly, although WT mice had a similar incidence of ventricular tachycardia induction by programmed electrical stimulation, as reported previously, 33 the S3E mice were highly resistant to the induction of life-threatening ventricular arrhythmias, and the S3A mice displayed increased arrhythmic susceptibility.
The results of the present study are consistent with prior in vitro studies using specific CK1␦ inhibitors that caused decreased gap junction formation, 8 as well as in vivo work using phosphospecific antibodies that found decreased expression of Cx43 phosphorylated at residues 325/328/330 in gap junctions after ischemia and TAC. 9, 10 The present data expand on these 
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findings by showing a link between phosphorylation of Cx43, GJR, and susceptibility to arrhythmia induction in vivo. Although S3A mutants were nonphosphorylated at serines 325/328/330, P2 and slower bands were present on immunoblotting of the Triton X-100 -insoluble fraction. This may indicate that CK1␦-dependent phosphorylation is electrophoretically silent but facilitates an additional phosphorylation event, which in turn is responsible for the formation of "P2." In this scenario, the second phosphorylation event responsible for P2 formation may be less efficient in the S3A mutants but not completely abrogated. Alternatively, it may simply be the case that with so many potential phosphorylatable residues within the carboxy-terminus of this gap junctional protein, the various "P" forms represent heterogeneous populations of Cx43 phosphoisoforms. Indeed, it has been shown that certain Cx43 phosphoisoforms can even migrate at P0. 8, 9, 42 Interestingly, the Cx43 phosphorylation-site mutations appear to differentially influence action potential properties. Mice expressing the S3A mutation displayed significantly longer APD 50 values and an increase in the dispersion of repolarization. Moreover, hearts from the S3A mice showed steeper restitution curves. Taken together, these properties may play an unexpectedly significant role in conferring the proarrhythmic phenotype observed in these mutant mice. Indeed, we previously reported significant electric remodeling in Cx43-deficient hearts. 38 These observations reinforce recent suggestions that the intercalated disc may act as a functional unit, with cross talk between connexins, scaffolding proteins such as ankyrins, and various sodium and potassium channel subunits. 39 There are several limitations to the present study. Although these experiments provide definitive evidence linking Cx43 phosphorylation state to gap junction stability and resistance to GJR, additional work will be required to more precisely identify what steps in the connexin life cycle are primarily responsible for this salutary behavior. One hypothesis for the increased stability seen with CK1␦ phosphorylated Cx43 is that phosphorylation at these sites confers protection from degradative pathways. Gap junctions are dynamic structures whose degradation involves internalization and eventual breakdown by both lysosomal [43] [44] [45] and proteasomal [45] [46] [47] [48] pathways. Ubiquitin conjugation to gap junctional Cx43 is thought to initiate endocytosis. The ubiquitin protein ligase Nedd4 is known to bind the carboxyl-terminus of Cx43, and the phosphorylation status of Cx43 may modulate this interaction. 49 Previous studies have shown that treatment of rat epithelial cells with epidermal growth factor and 12-O-tetradecanoylphorbol-13-acetate induces ubiquitination of Cx43, and this process is associated with hyperphosphorylation of Cx43 by mitogen-activated protein kinase and protein kinase C. 50 These findings illustrate the close relationship between Cx43 phosphorylation status and ubiquitination, as well as the importance of specific target residues. It is conceivable that phosphorylation at serines 325/328/330 interferes with endocytosis and subsequent degradation of gap junctions, whereas dephosphorylation at these sites enhances degradation. Our studies using heterologous expression systems have suggested the half-lives of the various mutant Cx43 proteins differ from WT Cx43; however, attempts to perform comparable studies in intact hearts with translational inhibitors have not been revealing. Alternatively, the major effect of Cx43 phosphorylation could involve trafficking. The S3E modification might augment (and conversely, the S3A mutation might inhibit) the direct targeting of connexons to the adherens junction. 51 Additional studies will be required to distinguish among these potential mechanisms.
Inasmuch as the phosphorylation status of Cx43 reflects the balance of various kinases and phosphatases such as CK1␦ and PP2A, we measured the abundance of these 2 enzymes. Given the recent report of increased expression of PP2A and enhanced association of PP2A with Cx43 in a model of nonischemic heart failure, we anticipated a similar finding in the hypertrophied hearts; however, we found no change in the abundance of either of CK1␦ or PP2A in hearts with pressure-overload hypertrophy and no evidence of increased interaction between PP2A and Cx43 (data not shown). Although this does not exclude changes in enzymatic activity, additional studies will be required to clarify the mechanisms responsible for the altered phosphorylation state of Cx43 we observed in hypertrophied hearts.
In summary, these data provide the first in vivo evidence to date of a mechanistic link between Cx43 phosphorylation status, gap junction expression, and arrhythmic susceptibility. Our results provide additional evidence indicating that modulation of Cx43 phosphorylation status may be a rational antiarrhythmic strategy. 52 
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